Evolva Holding en liquidation Ltd - Company Profile

Powered by

All the data and insights you need on Evolva Holding en liquidation Ltd in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Evolva Holding en liquidation Ltd Strategy Report

  • Understand Evolva Holding en liquidation Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Evolva Holding en liquidation Ltd: Overview

Select Item

Evolva Holding en liquidation Ltd (Evolva), formerly Evolva Holding SA, is a biotechnology company that develops, produces, and supplies high-purity nature-based ready-to-formulate ingredients with applications in the flavor, dietary supplements, cosmetics, and pharmaceutical sectors. The company's product portfolio comprises L-Arabinose, Stevia, Resveratrol, Nootkatone, NootkaSHIELD and Valencene. Evolva’s products find application in diverse areas, including food, nutrition, pharmaceuticals, pest control, and others. The company also provides health ingredients and scientific and technical support to its customer base. Evolva markets its products under the Evolva, Veri-te, L-Arabinose, and EverSweet brand names. It has a business presence in the US, the UK, Switzerland, Denmark, and India. Evolva is headquartered in Reinach, Switzerland.

 Gain a 360-degree view of Evolva Holding en liquidation Ltd and make more informed decisions for your business Gain a 360-degree view of Evolva Holding en liquidation Ltd and make more informed decisions for your business Find out more
Headquarters Switzerland
Address Duggingerstrasse 23, Reinach, CH-4153
Website www.evolva.com
Telephone 41 61 4852000
No of Employees 49
Industry Ingredients
Ticker Symbol & Exchange EVE (SWF)
Revenue (2022) $4.6M 517.5% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -22.1% (2022 vs 2021)
Market Cap* $8.3M
Net Profit Margin (2022) XYZ 80.2% (2022 vs 2021)
* As of and is in US$
View Evolva Holding en liquidation Ltd financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Products and Services

Products Brands
Resveratrol Evolva
L-Arabinose Veri-te
Valencene L-Arabinose
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Evolva Holding en liquidation Ltd portfolio and identify potential areas for collaboration Understand Evolva Holding en liquidation Ltd portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In November, the company entered into an agreement with Breko for the exclusive distribution of Veri-teTM Resveratrol in Germany, Austria, Thailand and Vietnam.
2023 Contracts/Agreements In September, the company entered into an agreement with LEHVOSS for distribution of Veri teTM resveratrol in over a dozen European countries.
2023 Contracts/Agreements In June, the company entered into an agreement with Nice & Green to secure financing.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Evolva Holding en liquidation Ltd Ingredion Inc Amyris Inc Basilea Pharmaceutica Ltd PureCircle Ltd
Headquarters Switzerland United States of America United States of America Switzerland Malaysia
City Reinach Westchester Emeryville Allschwil Kuala Lumpur
State/Province - Illinois California - Kuala Lumpur (Federal Territory of)
No. of Employees 49 11,600 1,598 147 1,100
Entity Type Public Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Beat In-Albon Vice Chairman Executive Board 2023 71
Christian Wichert Chief Executive Officer Senior Management 2022 49
Carsten Däweritz Chief Financial Officer Senior Management 2021 50
Gerhard Lobmaier Chief Operating Officer Senior Management 2021 54
Anne De Vos Chief Commercial Officer Senior Management 2022 59
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Evolva Holding en liquidation Ltd key executives to enhance your sales strategy Gain insight into Evolva Holding en liquidation Ltd key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward